To investigate this, Lewis rat macrophages were treated with the NLRP3 inflammasome inhibitor MCC950 (20) or with the caspase-1 inhibitor VX765 (which should inhibit all inflammasomes) (21) followed by Toxoplasma type I (RH) parasite infection. Here, NLRP3 is linked to parasitic infectious disease.